Perspective Therapeutics, Inc. — Director's Dealing 2018

Jul 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-06-26

Reporting Person: McCormick Michael W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-26	Stock Options (right to buy)	$0.45	A	5000	Acquired	2028-06-26	Common Stock (5000)	Direct

Footnotes

F1: 25% vested as of 6/26/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/26/2019, until fully vested.